| scholarly article | Q13442814 |
| meta-analysis | Q815382 |
| P50 | author | John Ioannidis | Q6251482 |
| Ewout W. Steyerberg | Q37828851 | ||
| P2093 | author name string | Joshua D Wallach | |
| Patrick G Sullivan | |||
| John F Trepanowski | |||
| P2860 | cites work | Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association | Q22306331 |
| Fibrates for secondary prevention of cardiovascular disease and stroke | Q24186376 | ||
| Home-based versus clinic-based specimen collection in the management of Chlamydia trachomatis and Neisseria gonorrhoeae infections | Q24186946 | ||
| Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users | Q24187451 | ||
| Drugs for preventing lung cancer in healthy people | Q24198265 | ||
| Ergonomic design and training for preventing work-related musculoskeletal disorders of the upper limb and neck in adults | Q24201555 | ||
| Green and black tea for the primary prevention of cardiovascular disease | Q24201918 | ||
| Strategies for managing sexual dysfunction induced by antidepressant medication | Q24202675 | ||
| Risperidone versus other atypical antipsychotics for schizophrenia | Q24234950 | ||
| Carotid endarterectomy for symptomatic carotid stenosis | Q24235277 | ||
| Nonlatex versus latex male condoms for contraception | Q24244624 | ||
| Effectiveness of brief alcohol interventions in primary care populations | Q24245140 | ||
| Alpha-glucosidase inhibitors for type 2 diabetes mellitus | Q24246908 | ||
| Reproducible Research Practices and Transparency across the Biomedical Literature | Q24288789 | ||
| Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal | Q24288920 | ||
| Systematic screening for the detection of atrial fibrillation | Q26471549 | ||
| Meta-analysis in clinical trials | Q27860779 | ||
| The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials | Q28185637 | ||
| The challenge of subgroup analyses--reporting without distorting | Q28235374 | ||
| Prognosis research strategy (PROGRESS) 4: Stratified medicine research | Q28709167 | ||
| Prognosis Research Strategy (PROGRESS) 2: Prognostic Factor Research | Q28709212 | ||
| The Path to Personalized Medicine | Q29541502 | ||
| 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association | Q29614695 | ||
| A new initiative on precision medicine | Q29615654 | ||
| Subgroup analysis and other (mis)uses of baseline data in clinical trials | Q30588628 | ||
| Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs | Q33174249 | ||
| Subgroup analyses in randomised controlled trials: cohort study on trial protocols and journal publications | Q33909616 | ||
| Adjuvant chemotherapy for localised resectable soft tissue sarcoma in adults | Q34062253 | ||
| Gender and the heart: sex-specific differences in normal anatomy and physiology. | Q34185818 | ||
| Credibility of claims of subgroup effects in randomised controlled trials: systematic review | Q34197712 | ||
| Is gender a risk factor for adverse drug reactions? The example of drug-induced long QT syndrome | Q34323705 | ||
| 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society | Q34412804 | ||
| Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study | Q34727157 | ||
| The influence of sex on pharmacokinetics | Q35049301 | ||
| The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method | Q35096756 | ||
| The influence of age and sex on the clearance of cytochrome P450 3A substrates | Q36000830 | ||
| Meta-analysis in clinical trials revisited | Q36264762 | ||
| The Effects of Antipsychotics on Prolactin Levels and Women's Menstruation. | Q37456024 | ||
| Diagnosis and treatment of heart disease: are women different from men? | Q37815916 | ||
| The influence of study characteristics on reporting of subgroup analyses in randomised controlled trials: systematic review | Q37858846 | ||
| Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: current practice and problems | Q39361114 | ||
| A consumer's guide to subgroup analyses | Q41111858 | ||
| Estimates of absolute treatment benefit for individual patients required careful modeling of statistical interactions | Q41151931 | ||
| Physiological Changes During the Menstrual Cycle and Their Effects on the Pharmacokinetics and Pharmacodynamics of Drugs | Q41734951 | ||
| Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses | Q45356123 | ||
| Subgroup analyses in therapeutic cardiovascular clinical trials: are most of them misleading? | Q46916326 | ||
| Statistical problems in the reporting of clinical trials. A survey of three medical journals | Q50147918 | ||
| Variation in surgical and anaesthetic technique and associations with operative risk in the European carotid surgery trial: implications for trials of ancillary techniques | Q51334465 | ||
| Statistics in medicine--reporting of subgroup analyses in clinical trials | Q51899945 | ||
| Misuse of Baseline Comparison Tests and Subgroup Analyses in Surgical Trials | Q59745904 | ||
| Prognostic or Predictive? It's Time to Get Back to Definitions! | Q60450796 | ||
| Empirical evaluation of very large treatment effects of medical interventions | Q85258093 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | meta-analysis | Q815382 |
| P304 | page(s) | i5826 | |
| P577 | publication date | 2016-11-24 | |
| P1433 | published in | The BMJ | Q546003 |
| P1476 | title | Sex based subgroup differences in randomized controlled trials: empirical evidence from Cochrane meta-analyses | |
| P478 | volume | 355 |
| Q92620615 | Does Sex Modify the Effect of Endovascular Treatment for Ischemic Stroke? |
| Q49494786 | Effect of Low-Fat vs Low-Carbohydrate Diet on 12-Month Weight Loss in Overweight Adults and the Association With Genotype Pattern or Insulin Secretion: The DIETFITS Randomized Clinical Trial |
| Q55246416 | Evaluation of person-level heterogeneity of treatment effects in published multiperson N-of-1 studies: systematic review and reanalysis. |
| Q47224501 | Gender differences in clinical registration trials; is there a real problem? |
| Q46535206 | Inclusion of Demographic-Specific Information in Studies Supporting US Food & Drug Administration Approval of High-Risk Medical Devices |
| Q38757690 | Long-term results and recurrence patterns from SCOPE-1: a phase II/III randomised trial of definitive chemoradiotherapy +/- cetuximab in oesophageal cancer. |
| Q89706239 | Patients' perspectives on participation in clinical trials and subsequent ethical challenges in a hospital setting in Jordan |
| Q64120111 | Personalized evidence based medicine: predictive approaches to heterogeneous treatment effects |
| Q91578049 | Quantifying Sex Bias in Clinical Studies at Scale With Automated Data Extraction |
| Q49407879 | Reporting of sex and gender in randomized controlled trials in Canada: a cross-sectional methods study. |
| Q88398324 | Sex and Gender Differences Research Design for Basic, Clinical, and Population Studies: Essentials for Investigators |
Search more.